Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …

Non-alcoholic fatty liver disease (NAFLD) affects over 30% of the United States population
and is projected to become a leading cause of chronic liver disease by 2020. As a result, the …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to
the global obesity epidemic. NAFLD comprises a systemic metabolic disease accompanied …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder in
the Western world. It is commonly associated with insulin resistance, obesity, dyslipidaemia …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western
countries. It encompasses a wide spectrum of liver lesions, from pure steatosis to end-stage …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease affecting approximately 25% of the global population. Although a majority of NAFLD …

Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four
decades ago. However, the condition has become the centre of attention within hepatology …

Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation
of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
encompasses a spectrum of pathology from simple steatosis to inflammation and significant …

Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver disorder in the
developed world affecting up to a third of individuals. It is closely associated with features of …